The goal of this prospective study is to evaluate the feasibility, sustainability, and public health impact of a district-based program for secondary prevention of Rheumatic Heart Disease (RHD) in Uganda.
Age range
5 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Proportion of persons with RHD reached by the ADUNU program
Timeframe: 5 year endpoint
Proportion of persons with RHD enrolled in care, retained and adherent to treatment
Timeframe: 3 months
Proportion of persons with RHD enrolled in care, retained and adherent to treatment
Timeframe: 24 months
Adoption and implementation of the ADUNU program at the organization level surveys
Timeframe: Baseline
Adoption and implementation of the ADUNU program at the organization level surveys
Timeframe: 24 months
Adoption and implementation of the ADUNU program at the provider level
Timeframe: 6 months
Adoption and implementation of the ADUNU program at the patient level interview
Timeframe: 24 months
Cost-analysis of the ADUNU program
Timeframe: 3 year endpoint